IRVINE, Calif., March 14 -- Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Citi 5th Annual Small and Mid-Cap Conference at the Four Seasons Hotel in Las Vegas on Wednesday, March 19, 2008.
Donald E. Bobo, Edwards Lifesciences' corporate vice president, heart valve therapy, is scheduled to speak to conference attendees at 1:05 p.m. PT. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies. In 2008, Edwards celebrates 50 years of partnering with clinicians to develop life-saving innovations. The company's global brands, which are sold in approximately 100 countries, include CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com/.
Source: Edwards Lifesciences Corporation
Media, Amanda Fowler,
Investors, David K.
both of Edwards Lifesciences Corporation
Web site: http://www.edwards.com/